CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.
CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.
复制标题
DOI:
10.4049/jimmunol.1501658
复制
发表时间:
2016-02-15
期刊:
影响因子:
--
通讯作者:
Zuniga EI
中科院分区:
文献类型:
--
作者:
Macal M;Tam MA;Hesser C;Di Domizio J;Leger P;Gilliet M;Zuniga EI
Type I interferons (IFN-I) are key innate mediators that create a profound antiviral state and orchestrate the activation of almost all immune cells. Plasmacytoid dendritic cells (pDCs) are the most powerful IFN-I producing cells and play important roles during viral infections, cancer, and autoimmune diseases. By comparing gene expression profiles of murine pDCs and conventional (c) DCs we found that CD28, a prototypic T cell stimulatory receptor, was highly expressed in pDCs. Strikingly, CD28 acted as a negative regulator of pDC IFN-I production upon toll-like receptor stimulation but did not affect pDC survival or maturation. Importantly, cell-intrinsic CD28 expression restrained pDC (and systemic) IFN-I production during in vivo RNA and DNA viral infections, limiting antiviral responses and enhancing viral growth early after exposure. Finally, CD28 also down-regulated IFN-I response upon skin injury. Our study identified a new pDC regulatory mechanism by which the same CD28 molecule that promotes stimulation in most cells that express it is co-opted to negatively regulate pDC IFN-I production and limit innate responses.